1. Public procurement

According our analysis from December 2014, competition in health care procurement is still low. The Ministry of Health has pledged to enact changes to achieve more transparent and more effective purchasing. We will focus on:

  • 3 case studies of public procurement with the aim to attract attention to cases of controversial procurement and possible savings
  • monitoring of the PPP project of the Hospital at Patrónka (Bratislava, Slovakia)
  • Enforcement of changes for more effective purchases (benchmarking, higher transparency, automatized auditing by the Ministry of Health)
  • Monitoring of implementation of the pledged made by the Ministry of Health

2. Conflict of interest of health care practitioners

The Ministry of Health has promised legislative changes for effective publication of information about collaboration of health care practitioners and pharmaceutical companies. With the aim to increase transparency we will focus on:

  • holding 10 lectures at health care sector events
  • preparing legislative changes in collaboration with the Ministry of Health
  • preparation of campaign to inform health care practitioners and patients about forthcoming changes

3. Oversight bodies

From the perspective of transparency and efficiency of health sector, an important role isfulfilled by oversight bodies such as the State Institute for Drug Control, the National Health Information Center and the Health Care Surveillance Authority. Transparency International Slovakia will prepare a case study focused on the transparent functioning of oversight bodies:

4. Ad hoc topics:

Space for monitoring of and commenting on topical problems concerning transparency and corruption in health care sector (100 media outputs).

Media

_________________________________________________________________________

In the second year our aim was to continue monitoring public procurement in healthcare with a special focus on state-owned hospitals; scrutinize the distribution of EU funds in healthcare; provide recommendations for the redrafting and implementation of conflict of interest policies and set up a web portal with accessible healthcare-related information, particularly information on the quality of hospitals.

The project was sponsored by Bayer, Union – Zdravotná poisťovňa, Amgen, GSK and Pfizer.

  1. Public Procurement in Healthcare.

We have calculated that more than 35 million EUR could be saved annually if all single-bid tenders in Slovak healthcare received at least two bids (almost 2/3 of all public procurement in Slovak healthcare is awarded in single-bid tenders). We aim to

  • Analyze public procurement on an annual basis
  • Prepare case studies drawing attention to controversial procurement and possible savings
  • Engage stakeholders in order to find solutions for more efficient procurement
  1. EU Funds in Healthcare

Hundreds of millions EUR are distributed via EU funds in healthcare. We aim to

  • Analyze distribution of EU funds and prepare case studies
  1. Conflicts of Interest

Many doctors are doing a poor job complying with legislation and reporting mutual financial relationships. At the same time, the legislation is far from perfect and the state is doing little to enforce it. We aim to

  • Call attention to laggards
  • Research policies in place abroad and their impact
  • Engage stakeholders to improve law and compliance
  • Launch an information campaign aimed at doctors explaining the rationale behind reporting conflicts of interest (conferences, articles, trainings)
  1. Healthcare Web Portal

Providing patients, the civil society and decision-makers with well-structured healthcare related information will improve patients’ access to quality healthcare while increasing competition in the market. Along with the INEKO Institute for Economic and Social Reforms we aim to create a web portal with health related information such as

  • Information on the quality and efficiency of hospitals – i.e. manner of communication with the public, indebtedness, competition in public procurement, complaints, patient surveys)
  • Information on the transparency of pharmaceutical companies
  • Information on doctors

5. Other Outputs

Media

_________________________________________________________________________

In the first year of the project, our aim was to monitor pharmaceuticals and medical device suppliers’ expenditures as well as their quality, analyze information disclosure, scrutinize ethics and quality in the pharmaceuticals and medical device categorization process as well as analyze healthcare foundations and NGOs donors.

The project was sponsored in its first year by Bayer, Dôvera zdravotná poisťovňa, Siemens, GlaxoSmithKline, Novartis Slovakia, and sanofi – aventis Pharma Slovakia.

1. Monitoring and analysis of pharmaceuticals and medical device suppliers’ expenditures

2. Analysis of ethics and quality in the process of categorization of pharmaceuticals and medical tools

3. Monitoring the quality and ethics of healthcare providers’ purchases of pharmaceuticals and medical devices

4. Analysis of donors sponsoring foundations and NGOs in healthcare

In the Media: